Many countries are racing to ensure a minimum supply of Covid-19 vaccine doses. According to a report by the NGO Oxfam, a group of countries representing 13 percent of the world's population has pre-purchased 50 percent of the future vaccine doses.
India
India alone is ahead of the European Union and the United States. The country has pre-ordered 1.6 billion doses. The orders were placed with AstraZeneca, Pfizer/BioNTech and Novavax.
The European Union
The European Commission is in charge of defining the vaccine supply strategy. It has ordered 1.4 billion doses for member countries, of which 15% are destined for France. The pre-orders are distributed as follows:
- 400 million doses from AstraZeneca
- 400 million doses from Johnson & Johnson
- 300 million doses from Sanofi-GSK
- 300 million doses from Pfizer/BioNTech
United States
The U.S. has ordered more than 1 billion doses from six laboratories. This order includes:
- 300 million doses of AstraZeneca's vaccine
- 100 million doses of Pfizer/BioNTech vaccine
- 100 million doses of Novavax vaccine
- 100 million doses of Sanofi-GSK and Johnson & Johnson vaccines
- 100 million doses of Moderna® vaccine
Canada
With a population of 38 million people, Canada has pre-ordered 358 million doses from seven different laboratories. Such massive order recognizes that some vaccines may fail clinical testing or validation by the Agency for Drugs and Technologies in Health:
- 76 million doses from Medicago
- 76 million doses from Novavax
- 72 million doses from Sanofi/GSK
- 56 million doses from Pfizer/BioNTech
- 38 million doses from Janssen Pharmaceutical Companies
- 20 million doses from AstraZenecal
- 20 million doses from Moderna
United Kingdom
The United Kingdom has already placed an order for 350 million doses with six laboratories, including:
- 100 million doses from AstraZenecal
- 60 million doses with Novavax
- 60 million doses from Sanofi-GSK
- 40 million doses from Pfizer/BioNTech
Read also | Covid-19 vaccine: poor countries will have to wait [4]